By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein
Many people would say they know what a diverse company is. Many could recite all the ways a company might encourage or increase diversity in its ranks. Many would recognize a diverse company if they saw one. But few people actually work in one.
We sought out a biopharma enterprise where diversity always has been an operating principle, where it feeds the company’s intellectual life and creative culture, and where it is demonstrable yet still evolving. Mink Therapeutics is the company, and Jennifer Buell is the president and CEO who has assembled a multiracial, multigender, and multipreference management team and workforce composed of a majority of women. The executive and scientific advisory boards are also multicultural, with women in high-level roles. “I came to be where I am and to think about building diverse and inclusive teams because of my background and my focus on science and evolution,” Buell says.